TRI-JORDYNA 28
GLENMARK PHARMACEUTICALS CANADA INC.
Quick answers
Is there a shortage of TRI-JORDYNA 28 in Canada?
No. There is no current shortage of TRI-JORDYNA 28 0.035MG 0.18MG 0.035MG 0.215MG 0.035MG 0.25MG reported to Health Canada. Stock can still vary from one pharmacy to another.
Can I still get this?No shortage reported — confirm local stock with your pharmacy
StatusNo shortage on file
Same-ingredient products on fileNone found
DIN
02486318
Strength
0.035MG 0.18MG 0.035MG 0.215MG 0.035MG 0.25MG
Dosage Form
TABLET
Route
ORAL
Active Ingredient
ETHINYL ESTRADIOL NORGESTIMATE
Compare with another product →
Shortage History
Other Products from GLENMARK PHARMACEUTICALS CANADA INC.
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
ATOVAQUONE AND PROGUANIL HYDROCHLORIDE TABLETS
DIN 02466783
DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS USP
DIN 02462060
DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS USP 21
DIN 02421437
DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS USP 28
DIN 02421445
GLN-APREMILAST
30MG · DIN 02518910
GLN-ATOVAQUONE
750MG · DIN 02528495
GLN-BILASTINE
20MG · DIN 02544369
GLN-DAPAGLIFLOZIN
10MG · DIN 02519860
GLN-DAPAGLIFLOZIN
5MG · DIN 02519852
GLN-GABAPENTIN
600MG · DIN 02410990
GLN-GABAPENTIN
800MG · DIN 02411008
GLN-OLMESARTAN
40MG · DIN 02469820